Pathophysiology of renal anemia

Clinical Nephrology

Volumn 53, Issue SUPPL. 1, 2000, Pages

  Eckardt, K U ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Anemia; Erythropoietin; Renal failure; Uremia

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN;

ANEMIA; CONFERENCE PAPER; ERYTHROCYTE LIFESPAN; ERYTHROPOIESIS; HORMONAL REGULATION; HUMAN; HYPERPARATHYROIDISM; IRON KINETICS; KIDNEY FAILURE; MECHANICAL STRESS; OCCULT BLOOD; OSMOTIC STRESS; PATHOPHYSIOLOGY; UREMIA;

ANEMIA; ERYTHROPOIETIN; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 0034108227     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (78)

1. Adamson MV, Eschbach JW 1989 Management of the anaemia of chronic renal failure with recombinant erythropoietin. Q J Med 272: 1093-1101
2. Allegro V, hlengozzi G, Martimbianco L, Vasile A 1996 Early and late effects of erythropoietin on glucose metabolism in maintenance hemodialysis patients. Am J Nephrol 16: 304-308
3. AsabaH, Bergstrom J, Lundgren G, SorboP. TranaeusA, Zachrisson L 1977 HyperSequestration of 51Crlabelled erythrocytes as a criterion for splenectomy in regular hemodialysis patients. Clin Nephrol 8: 304-307
4. Bachmann S, Le Mir M, Eckardt KU1993 Colocalization of erythropoietin mRNA ecto-5'-nucIeotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 41: 335-341
5. Balaskas EV, Melamed IR, Gupta A, Bargman J, Oreopoulos DC 1993 Effect of erythropoietin treatment on nutritional status of continuous ambulatory peritoneal dialysis patients. Peril Dial Int 13: S544-S549
6. Barany P. Petterson E, Konarski-Svensson JK 1993 Long-term effects on quality of life in haemodialysis patients of correction of anaemia with erythropoietin. Nephrol Dial Transplant 8: 426-432
7. Benigni A, BoccardoP, Galbusera Met at. 1993 Reversible activation defect of the platelet glycoprotein Ilb-IIIa complex in patients with uremia. Am J Kidney Dis 22:668-676
8. Beusterien KM, Nissenson AR, Port FK, Kelly M, Stein wald M, Ware JEjr 1996 The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol 7: 763-773
9. Bommer J, Kugel M, Schwöbel B. Ritz E, Barth HP, Seelig R 1990 Improved sexual function during recombinant human erythropoietin therapy. Nephrol Dial Transplant 5:204-207
10. Bright R 1836 Cases and observations, illustrative of renal disease accompanied with the secretion of albuminous urine. Guys Hosp Rep J.- 338-400
11. Carlson DJ, Shapiro FL 1970 Methemoglobinemia from well water nitrates: A complication of home dialysis. Ann Intern Med 73: 757-759
12. Cam J, Brown S, Miller O, Murray T, Erslev AJ 1979 Erythropoietin levels in urémie nephric and anephric patients. J Lab Clin Med 93:449-458
13. Chandra M, Miller ME, Garcia JF, Mossey RT, McVicar M 1985 Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients. Nephron 39: 26-29
14. Chandra M, demons GK, McVicar M1988 Relation of serum erythropoietin levels to renal excretory function: Evidence for lowered set point for erythropoietin production in chronic renal failure. J Pediatr 113: 1015-1021
15. Cotes PM 1982 Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates. Br J Haematol JO: 427-438
16. Cotes PM. PippardMJ, ReidCD, IHnearls CG, Oliver DO, RoystonJP 1989 Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics. Q J Med 70: 113-137
17. Delwiche F, Segal CM, Eschbach JW, Adamson JW 1986 Hematopoietic inhibitors in chronic renal failure: Lack of in vitro specificity. Kidney Int 29: 641-648
18. DeMarchiS, CecchinE, Villalta D, Sepiacci G, Santini G, BartoliE 1992 Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia. N Engl J Med 326: 969-974
19. DePaepe MBJ, Schelstraete KHG, Ringoir SMG, Lameire NH 1983 Influence of continuous ambulatory peritoneal dialysis on the anemia of end-stage renal disease. Kidney Int 23: 744-748
20. Desforges JF, Dawson JP 1958 The anemia of renal failure. Arch Intern Med 101: 326-332
21. Eaton JW, Kolpin CF. Swofford HS, Kjellstrand CM, Jacob HS 1973 Chlorinated urban water: a cause of dialysis-induced hemolytic anemia. Science 181: 463-464
22. Eckardt KU. Kurtz A, Bauer C 1989a Regulation of erythropoietin formation is related to proximal tubular function. Am J Physiol 256: F942-F947
23. Eckardt KU, Möllmann M, Neumann R, Brunkhorst R, Burger HU, Lonnemann G, Scholz H, Keusch G, Bucliliolz B, Frei U, Bauer C, Kurtz A 1989b Erythropoietin in polycystic kidneys. J Clin Invest 84: 1160-1166
24. Eckardt KU, KouryST. Tan CC, Schuster SJ, Ratcliffe PJ, KaisslingB, Kurtz A 1992 Distribution of erythropoietin-producing cells in rat kidneys during hypoxic hypoxia. Kidney Int 43: 815-823
25. Eckardt KU 1994 Erythropoietin: oxygen-dependent control of erythropoiesis and its failure in renal disease. Nephron 67: 7-23
26. Eckardt KU 1996 Erythropoietin production in liver kidneys. Curr Opin Nephrol Hypertens J: 28-34
27. Eckardt KU 1999 Cardiovascular consequences of renal anemia and erythropoietin therapy. Nephro Dial Transpl 74:1317-1323
28. Erslev AJ, Besarab A 1997 Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure. Kidney Int 57: 622-630
29. Eschbach JW, Funk D, Adamson J, Kulm I, Scribner BH, Finch CA 1967 Erythropoiesis in patients with renal failure undergoing chronic hemodialysis. N Engl J Med 276: 653-658
30. Eschbach JW, Adamson JW, CookJD 1973 Disorders of red cell production in uremia. Arch Int Med 78: 527-534
31. Eschbach JW, Haley NR, Egrie JC, Adamson JW 1992 A comparison of the responses to recombinant human erythropoietin in normal and urémie subjects. Kidney Int 42:407-416
32. Foley RN, Parfrey PS, Harnett JD, Kent GM. Murray DC, Barre PE 1996 The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28:53-61
33. Garcia JF, Ebbe SN, Hollander L, Cutting HO, Miller ME, Cronkite E 1982 Radioimmunoassay of erythropoietin: circulating levels in normal polycythemic human beings. J Lab Clin Med 99: 624-635
34. Greaves SC. Gamble CD, Collins JF, Whalley GA, SharpeDiVl994 Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure. Am J Kidney Dis 14: 768-776
35. Hartley LCJ, Innis MD, Morgan TO. Clunie G JA 1971 Splenectomy for anaemia in patients on regular haemodialysis. Lancet 2: 1343-1345
36. HeftiJE, BlumbergA, MartiHR 1983 Red cell survival and red cell enzymes in patients on continuous peritoneal dialysis (CAPD). Clin Nephrol 79: 232-235
37. Hocken AG, Manvah PK 1971 latrogenic contribution to anaemia of chronic renal failure. Lancet 7: 164-165
38. Ifudu O, FeldmanJ, Friedman EA 1996 The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 334:420-425
39. Jacobson LO, Goldwasser E, Fried W, Plzak L 1957 Role of the kidney in erythropoiesis. Nature 779: 633-634
40. Jelkmann W 1992 Erythropoietin: Structure, control of production, and function. Physiol Rev 72: 449-489
41. Jelkmann W, Pagel H. Wolff M, Fandrey J 1992 Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sei 50: 301-308
42. Joske RA, McAlisterJM. Prankerd TAJ 1956 Isotope investigations of red cell production and destruction in chronic renal disease. Clin Sei 75: 511-516
43. Kalo A, HishidaA, KumagaiH, FuruyaR, Nakajima T, Hondo N1994 Erythropoietin production in patients with chronic renal failure. Ren Fail 76: 645-651
44. Kaupke CJ, Vaziri ND 1993 Effect of recombinant erythropoietin on electrolytes and nutrition in end-stage renal disease patients (editorial). Int J Artif Organs 76: 59-62
45. Koch KM, Patyna D, Shaldon S, Werner E 1974 Anemia of the regular hemodialysis patient and its treatment. Nephron 12:405-419
46. Koury ST, Koury MJ, Bondurant MC, Cam J, Graber SE 1989 Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood 74: 645-651
47. KrantzSB 1991 Erythropoietin. Blood 77: 419-434
48. KiirtzA. ZapfJ, Eckardt KU. demons GK, Froesch ER, Bauer C 1988 Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats. Proc Nail Acad Sei USA 85: 7825-7829
49. Lerner R, Werner B, Asaba H, Ternstedt B, Elmqvist E 1983 Assessment of hemolysis in regulär hemodialysis patients by measuring carbon monoxide production rate. Clin Nephrol 20: 239-243
50. Levin A, Singer J, Thompson CR, Ross H, Lewis At 1996 Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 27: 347-354
51. Union AL, Clark WF. DriedgerAA, Werb R. Lindsay RM 1977 Correctable factors contributing to the anemia of dialysis patients. Nephron 19: 95-98
52. Macdougall 1C, Lewis NP, Sounders MJ et al 1990 Long-term cardiorespiratory effects of amelioration of renal anemia by erythropoietin. Lancet 335:489-493
53. ManilerAD, SchreinberAW 1970 Copper-induced acute hemolytic anemia. A new complication of hemodialysis Ann Intern Med 73:409-412
54. Marrades PM, Roca J, Campistol JM, Diaz O, Barbera JA, Torregrosa JV, Masclans JR, Cobos A, Rodrigues-Roisin R, Wagner PD 1996 Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure. J Clin Invest 97: 2092-2100
55. Maxu-ellPH. Osmond MK, Pugh CW, HeiyetA. Nicholls LG, Tan CC, Doe BC, Ferguson DJP, Johnson MH. Ratcliffe PJ 1993 Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 44: 1149-1162
56. Mayer G, Hörl WH 1996 Cardiovascular effects of increasing hemoglobin in chronic renal failure. Am J Kidney Dis 16: 263-267
57. Muirhead N, Hodsman AB, Hollomby DJ, Cordy PE 1991 The role of aluminium and parathyroid hormone in erythropoietin resistance in hemodialysis patients. Nephrol Dial Transplant 6: 342-345
58. OrringerEP, Mattern WDL 1976 Formaldehyde-induced hemolysis during chronic hemodialysis. N Engl J Med 294: 1416-1420
59. Pavlovic-Kentera V, demons GK, Djukanovic L, Biljanovic-Paunovic L 1987 Erythropoietin anemia in chronic renal failure. Exp Hematol 15: 785-789
60. Pétrie J, RowJPG 1977 Dialysis anaemia caused by subacute zinc toxicity. Lancet 1: 1178-1180
61. Radermacher J, Koch KM 1995 Treatment of renal anemia by erythropoietin substitution - The effects on the cardiovascular system. Clin Nephrol 44: S56-S60
62. Rao DS, Sliih MS, Mohini R 1993 Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 328: 171-175
63. Rosenmund A, Binswanger U, Sträub PW 1975 Oxidative injury to erythrocytes, cell rigidity, and splenic hemolysis in hemodialyzed urémie patients. Ann Intern Med 82:460-465
64. Rosse WF, TA Waldmann, P Cohen 1963 Renal cysts, erythropoietin and polycythemia. Am J Med 34:76-81
65. SchaeferRM, Kokot F, Wcrnze H, Geiger H, Heidland A 1989 Improved sexual function in hemodialysis patients on recombinant erythropoietin: a possible role for prolactin. Clin Nephrol 31: 1-5
66. Segal GM, Eschbach JW, Egrie JC, Stueve T, Adamson JW 1988 The anemia of end-stage renal disease: Hematopoietic progenitor cell response. Kidney Int 33: 983-988
67. SennesaelJJ, Van der Niepen P, VerbcelenD 1991 Treatment with recombinant human erythropoietin increases antibody titers after hepatitis B vaccination in dialysis patients. Kidney Int 40: 121-128
68. Shalonb RJ, Uma R. Kim W, Goldwasser E, Kark JA, Antoniou LD 1982 Erythrocytosis in patients on long-term hemodialysis. Ann Intern Med 97: 686690
69. Shaw AB 1967 Haemolysis in chronic renal failure. Br Med J 2: 213-216
70. Silberberg JS, Barre PE, Prichard SS, Sniderman SD 1989 Impact of left-ventricular hypertrophy on end-stage renal disease. Kidney Int 36: 286-290
71. Tan CC, Eckardt KU, Ratcliffe PJ 1991 Organ distribution of erythropoietin messenger RNA in normal and urémie rats. Kidney Int 40: 69-76
72. Tan CC, Eckardt KU, Firth J, Ratcliffe PJ 1992 Feedback modulation of renal and hepatic erythropoietin messenger RNA in response to graded anemia and hypo.xia. Am J Physiol 263: F474-F481
73. Tercedor J, Lopez-Hernandez B, Rodenas JM, Herranz MT, Serrano-Ortega S 1991 Erythropoietin therapy for urémie pruritus. N Engl J Med 527; 734
74. Vigano G, Benigni A, Mendogni D, Mingardi G, Mecca G, Remuzzi G 199I Recombinant human erythropoietin to correct urémie bleeding. Am J Kidney Dis 18: '44-49
75. (lallner SF, Vautrin RM 1981 Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure. J Lab Clin Med 97: 170-178
76. Whitehead VM, CH Comply, G A Posen, M Kaye 1968 I lomeostasis of folic acid in patients undergoing maintenance hemodialysis. N Engl J Med 279: 970-974
77. ttlzemann V, Kaufmann J, Kramer W 1992 Effect of erythropoietin on ischemia tolerance in anemic hemodialysis patients with confirmed coronary artery disease. Nephron 62: 161-165
78. ZingraffJ, Dnieke T, Mane P, Khoa Man N, Jungers P, Bordier P 1978 Anemia and secondary hyperparathyroidism. Arch Intern Med 138: 1650-1652